Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dentinger, P. J.
Right arrow Articles by Swenson, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dentinger, P. J.
Right arrow Articles by Swenson, C. F.
American Journal of Health-System Pharmacy, Vol. 64, Issue 24, 2569-2573
Copyright © 2007. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Practice Report

Stability of codeine phosphate in an extemporaneously compounded syrup

Paul J. Dentinger and Chad F. Swenson

PAUL J. DENTINGER, M.S., is Chemist; and CHAD F. SWENSON, B.S.PHARM., is Supervisor of Manufacturing Service, Department of Pharmacy, Strong Memorial Hospital, Rochester, NY.

Address correspondence to Mr. Swenson at the Department of Pharmacy, University of Rochester Medical Center, Box 638, 601 Elmwood Avenue, Rochester, NY 14642 (chad_swenson{at}urmc.rochester.edu).


Purpose. The stability of codeine phosphate in an extemporaneously compounded syrup is described.

Methods. Codeine phosphate 3-mg/mL syrup was prepared using commercially available Codeine Phosphate, USP, Sterile Water for Irrigation, USP, and Ora-Sweet syrup vehicle. Samples were stored in amber polyethylene terephthalate bottles with child-resistant caps. A second batch of codeine phosphate 3-mg/mL syrup was prepared and drawn into amber polyethylene oral syringes with silicon elastomer tips. All samples were stored at room temperature and in the dark. Samples were analyzed immediately and at 7, 14, 28, 42, 56, 70, and 98 days. Codeine phosphate concentrations were measured using a modified stability-indicating high-performance liquid chromatographic method. At each test interval, the density of the syrup was determined gravimetrically using a 10-mL amber oral syringe. Excessive degradation was defined as a greater than 7% loss of the initial concentration.

Results. The stock internal standard was stable for at least 98 days at room temperature. The compounded syrup retained more than 93% of the initial codeine phosphate concentration for at least 98 days at 22–25 °C. No changes in color, clarity, or odor and no visible solids or microbial growth were observed in any sample. The pH of the syrup was initially 4.2 and remained unchanged throughout the study.

Conclusion. Codeine phosphate 3 mg/ mL in Ora-Sweet syrup vehicle was stable in both amber polyethylene terephthalate bottles and amber polyethylene oral syringes for at least 98 days when stored at 22–25 °C and protected from light.

Index terms: Chromatography, liquid; Closures; Codeine phosphate; Color; Compounding; Concentration; Containers; Contamination; Density; Hydrogen ion concentration; Odors; Opiates; Polyethylene terephthalate; Polyethylene; Silicone elastomers; Stability; Storage; Syringes; Syrups; Vehicles; Water for Injection

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Health-System Pharmacists.